1959
DOI: 10.1172/jci103864
|View full text |Cite
|
Sign up to set email alerts
|

Studies in Kernicterus. I. The Protein Binding of Bilirubin*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
81
0
4

Year Published

1960
1960
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 309 publications
(90 citation statements)
references
References 29 publications
5
81
0
4
Order By: Relevance
“…A 10 to 20 mg/kg loading dose of bilirubin was given followed by a continuous or intermittent (every 15-30 min) infusion of the bilirubin solution until either a total dose of about 150 mg/kg was given (usually 3-4 h) or obvious ABR abnormalities developed. If no ABR changes were apparent, the infant was given 200 mg/kg of sulfisoxazole intravenously (15). Periodic blood samples were obtained from a site remote from the bilirubin administration site, for measurement of the total and direct serum bilirubin concentration and, in some animals, the serum albumin and unbound bilirubin concentrations (I 6, 17).…”
Section: Methodsmentioning
confidence: 99%
“…A 10 to 20 mg/kg loading dose of bilirubin was given followed by a continuous or intermittent (every 15-30 min) infusion of the bilirubin solution until either a total dose of about 150 mg/kg was given (usually 3-4 h) or obvious ABR abnormalities developed. If no ABR changes were apparent, the infant was given 200 mg/kg of sulfisoxazole intravenously (15). Periodic blood samples were obtained from a site remote from the bilirubin administration site, for measurement of the total and direct serum bilirubin concentration and, in some animals, the serum albumin and unbound bilirubin concentrations (I 6, 17).…”
Section: Methodsmentioning
confidence: 99%
“…The sulfisoxazole experience alerted clinicians to the role of UCB binding in the pathogenesis of ABE, and methods for measuring UCB binding were pursued in hopes of better identifying babies truly needing a potentially lifesaving but also very risky exchange transfusion (4 ). Measuring B f directly proved elusive, however, and the early tests measuring plasma "saturation" with UCB (i.e., plasma UCB-binding capacity) ultimately proved unsuitable for routine clinical laboratory use (39,40 ).…”
Section: Where's the B F ? A Brief Clinical History Of Abe B T Andmentioning
confidence: 99%
“…Although a serum bilirubin concentration of 20 mg/ 100 ml (Hsia, Allen, Gellis and Diamond, 1952) is often taken as that at which treatment should be undertaken, other factors, including albumin binding capacity (Darrow and Cary, 1933;Odell, 1959) and blood pH (Keay and Boyle), must be taken into consideration. The proper assessment of the situation depends upon repeated determinations of serum bilirubin concentration.…”
Section: Fig I-absorption Spectra Of Bilirubin ( ---) and Haemoglobmentioning
confidence: 99%